Premier Alternatives

Precision Neuroscience

New York, NY · Founded 2021 · Privately Held (backing)

Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses. Precision Neuroscience is based in New York, NY and was founded in 2021. It was valued at $529 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $179 million across 4 recorded rounds; the latest was a $93.1 million later-stage round in Oct 2024.

PMV mark · valuation
$529.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$179.1M
Last round
Later Stage VC
Oct 2024

Precision Neuroscience key facts

as of Oct 2026
  • Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses.
  • Precision Neuroscience is valued at approximately $529.0M as of Oct 2026, set at its later-stage round, Oct 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $179.1M across 4 recorded rounds; the latest was Later Stage VC ($93.1M) in Oct 2024.
  • Notable investors include Alumni Ventures, Draper Associates, Korea Investment Partners, B Capital Group, Chestnut Street Ventures — 17 tracked in total.
  • Precision Neuroscience has filed 5 Form Ds with the SEC since 2021, most recently Oct 2024 ($93.1M sold to 21 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$529.0M

Valued at $529.0M at its later-stage round, Oct 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Precision Neuroscience with a free account
  • ·The complete investor list: 17 names
  • ·Watch Precision Neuroscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Precision Neuroscience funding rounds

4 rounds
Oct 2024Later Stage VC$93.1MSEC filing▮
Mar 2024Early Stage VC$27.5MSEC filing▮
Dec 2022Early Stage VC$41.2MSEC filing▮
Apr 2021Early Stage VC$10.5MSEC filing▮
Full funding history →

Precision Neuroscience valuation

Precision Neuroscience was valued at $529 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Precision Neuroscience raised?

Precision Neuroscience has raised $179 million across 4 recorded rounds since 2021. The largest was a $93.1 million later-stage round in Oct 2024.

Precision Neuroscience has filed 5 Form Ds with the SEC since 2021, most recently in Oct 2024 ($93.1 million sold to 21 investors).

Precision Neuroscience investors

17 investors are on record for Precision Neuroscience, including Alumni Ventures, Draper Associates, Korea Investment Partners and B Capital Group. By type, the record holds 5 venture capital firms, 3 asset managers and 2 private equity firms. The later-stage round in Oct 2024 drew 21 investors.

About Precision Neuroscience

Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses. The company's thin-film microelectrode array conforms to the brain surface without penetrating tissue, collecting and processing large amounts of neural data across multiple brain regions, enabling medical providers to treat conditions such as spinal cord injuries, stroke, and neurodegenerative diseases.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2021
Employees
115
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.